201 related articles for article (PubMed ID: 32062817)
21. Segmenting white matter hyperintensities on isotropic three-dimensional Fluid Attenuated Inversion Recovery magnetic resonance images: Assessing deep learning tools on a Norwegian imaging database.
Røvang MS; Selnes P; MacIntosh BJ; Rasmus Groote I; Pålhaugen L; Sudre C; Fladby T; Bjørnerud A
PLoS One; 2023; 18(8):e0285683. PubMed ID: 37616243
[TBL] [Abstract][Full Text] [Related]
22. HIV infection and cerebral small vessel disease are independently associated with brain atrophy and cognitive impairment.
Sanford R; Strain J; Dadar M; Maranzano J; Bonnet A; Mayo NE; Scott SC; Fellows LK; Ances BM; Collins DL
AIDS; 2019 Jun; 33(7):1197-1205. PubMed ID: 30870193
[TBL] [Abstract][Full Text] [Related]
23. Sex differences in the development of mild cognitive impairment and probable Alzheimer's disease as predicted by hippocampal volume or white matter hyperintensities.
Burke SL; Hu T; Fava NM; Li T; Rodriguez MJ; Schuldiner KL; Burgess A; Laird A
J Women Aging; 2019; 31(2):140-164. PubMed ID: 29319430
[TBL] [Abstract][Full Text] [Related]
24. White matter hyperintensities and neuropsychiatric symptoms in mild cognitive impairment and Alzheimer's disease.
Misquitta K; Dadar M; Louis Collins D; Tartaglia MC;
Neuroimage Clin; 2020; 28():102367. PubMed ID: 32798911
[TBL] [Abstract][Full Text] [Related]
25. Altered amplitude of low-frequency fluctuations in early and late mild cognitive impairment and Alzheimer's disease.
Liang P; Xiang J; Liang H; Qi Z; Li K; Alzheimer's Disease NeuroImaging Initiative
Curr Alzheimer Res; 2014 May; 11(4):389-98. PubMed ID: 24720892
[TBL] [Abstract][Full Text] [Related]
26. Comparison and validation of seven white matter hyperintensities segmentation software in elderly patients.
Vanderbecq Q; Xu E; Ströer S; Couvy-Duchesne B; Diaz Melo M; Dormont D; Colliot O;
Neuroimage Clin; 2020; 27():102357. PubMed ID: 32739882
[TBL] [Abstract][Full Text] [Related]
27. Elevated Homocysteine Levels and Hypertension Relate to Cognitive Impairment via Increased White Matter Hyperintensity Volume.
Gao Y; Duan X; Li W; Zhang X; Xian X; Zhu Y; Wang H;
J Alzheimers Dis; 2023; 96(4):1739-1746. PubMed ID: 38007660
[TBL] [Abstract][Full Text] [Related]
28. Etiology of White Matter Hyperintensities in Autosomal Dominant and Sporadic Alzheimer Disease.
Shirzadi Z; Schultz SA; Yau WW; Joseph-Mathurin N; Fitzpatrick CD; Levin R; Kantarci K; Preboske GM; Jack CR; Farlow MR; Hassenstab J; Jucker M; Morris JC; Xiong C; Karch CM; Levey AI; Gordon BA; Schofield PR; Salloway SP; Perrin RJ; McDade E; Levin J; Cruchaga C; Allegri RF; Fox NC; Goate A; Day GS; Koeppe R; Chui HC; Berman S; Mori H; Sanchez-Valle R; Lee JH; Rosa-Neto P; Ruthirakuhan M; Wu CY; Swardfager W; Benzinger TLS; Sohrabi HR; Martins RN; Bateman RJ; Johnson KA; Sperling RA; Greenberg SM; Schultz AP; Chhatwal JP;
JAMA Neurol; 2023 Dec; 80(12):1353-1363. PubMed ID: 37843849
[TBL] [Abstract][Full Text] [Related]
29. Microglial activation and tau burden predict cognitive decline in Alzheimer's disease.
Malpetti M; Kievit RA; Passamonti L; Jones PS; Tsvetanov KA; Rittman T; Mak E; Nicastro N; Bevan-Jones WR; Su L; Hong YT; Fryer TD; Aigbirhio FI; O'Brien JT; Rowe JB
Brain; 2020 May; 143(5):1588-1602. PubMed ID: 32380523
[TBL] [Abstract][Full Text] [Related]
30. Regional White Matter Hyperintensities and Alzheimer's Disease Biomarkers Among Older Adults with Normal Cognition and Mild Cognitive Impairment.
Newton P; Tchounguen J; Pettigrew C; Lim C; Lin Z; Lu H; Moghekar A; Albert M; Soldan A;
J Alzheimers Dis; 2023; 92(1):323-339. PubMed ID: 36744337
[TBL] [Abstract][Full Text] [Related]
31. Correlating Cognitive Decline with White Matter Lesion and Brain Atrophy Magnetic Resonance Imaging Measurements in Alzheimer's Disease.
Bilello M; Doshi J; Nabavizadeh SA; Toledo JB; Erus G; Xie SX; Trojanowski JQ; Han X; Davatzikos C
J Alzheimers Dis; 2015; 48(4):987-94. PubMed ID: 26402108
[TBL] [Abstract][Full Text] [Related]
32. Association between brain amyloid deposition and longitudinal changes of white matter hyperintensities.
Cha WJ; Yi D; Ahn H; Byun MS; Chang YY; Choi JM; Kim K; Choi H; Jung G; Kang KM; Sohn CH; Lee YS; Kim YK; Lee DY
Alzheimers Res Ther; 2024 Mar; 16(1):50. PubMed ID: 38454444
[TBL] [Abstract][Full Text] [Related]
33. The effect of white matter hyperintensities on cognition is mediated by cortical atrophy.
Rizvi B; Narkhede A; Last BS; Budge M; Tosto G; Manly JJ; Schupf N; Mayeux R; Brickman AM
Neurobiol Aging; 2018 Apr; 64():25-32. PubMed ID: 29328963
[TBL] [Abstract][Full Text] [Related]
34. Beware of white matter hyperintensities causing systematic errors in FreeSurfer gray matter segmentations!
Dadar M; Potvin O; Camicioli R; Duchesne S;
Hum Brain Mapp; 2021 Jun; 42(9):2734-2745. PubMed ID: 33783933
[TBL] [Abstract][Full Text] [Related]
35. Memory decline in elderly with cerebral small vessel disease explained by temporal interactions between white matter hyperintensities and hippocampal atrophy.
van Leijsen EMC; Tay J; van Uden IWM; Kooijmans ECM; Bergkamp MI; van der Holst HM; Ghafoorian M; Platel B; Norris DG; Kessels RPC; Markus HS; Tuladhar AM; de Leeuw FE
Hippocampus; 2019 Jun; 29(6):500-510. PubMed ID: 30307080
[TBL] [Abstract][Full Text] [Related]
36. Cognitive reserve and clinical progression in Alzheimer disease: A paradoxical relationship.
van Loenhoud AC; van der Flier WM; Wink AM; Dicks E; Groot C; Twisk J; Barkhof F; Scheltens P; Ossenkoppele R;
Neurology; 2019 Jul; 93(4):e334-e346. PubMed ID: 31266904
[TBL] [Abstract][Full Text] [Related]
37. Longitudinal Neuroimaging Hippocampal Markers for Diagnosing Alzheimer's Disease.
Platero C; Lin L; Tobar MC
Neuroinformatics; 2019 Jan; 17(1):43-61. PubMed ID: 29785624
[TBL] [Abstract][Full Text] [Related]
38. Periventricular white matter hyperintensities and the risk of dementia: a CREDOS study.
Kim S; Choi SH; Lee YM; Kim MJ; Kim YD; Kim JY; Park JH; Myung W; Na HR; Han HJ; Shim YS; Kim JH; Yoon SJ; Kim SY; Kim DK
Int Psychogeriatr; 2015 Dec; 27(12):2069-77. PubMed ID: 26212042
[TBL] [Abstract][Full Text] [Related]
39. White matter hyperintensities and cerebral amyloidosis: necessary and sufficient for clinical expression of Alzheimer disease?
Provenzano FA; Muraskin J; Tosto G; Narkhede A; Wasserman BT; Griffith EY; Guzman VA; Meier IB; Zimmerman ME; Brickman AM;
JAMA Neurol; 2013 Apr; 70(4):455-61. PubMed ID: 23420027
[TBL] [Abstract][Full Text] [Related]
40. Cerebrospinal fluid synaptosomal-associated protein 25 is a key player in synaptic degeneration in mild cognitive impairment and Alzheimer's disease.
Zhang H; Therriault J; Kang MS; Ng KP; Pascoal TA; Rosa-Neto P; Gauthier S;
Alzheimers Res Ther; 2018 Aug; 10(1):80. PubMed ID: 30115118
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
